Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls

被引:111
作者
Miosge, N
Sasaki, T
Timpl, R
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Univ Gottingen, Abt Histol, Zentrum Anat, D-37075 Gottingen, Germany
关键词
binding assays; extracellular matrix; immunogold staining;
D O I
10.1096/fasebj.13.13.1743
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The endothelial cell inhibitor endostatin (22 kDa) is part of the carboxyl-terminal globular domain of collagen XVIII and shows a widespread tissue distribution. Immunohistology of adult mouse tissues demonstrated a preferred localization in many vessel walls and some other basement membrane zones. A strong immunogold staining was observed across elastic fibers in the multiple elastic membranes of aorta and other large arteries. Staining was less strong along sparse elastic fibers of veins and almost none was observed in the walls of arterioles and capillaries. Strong evidence was also obtained for some intracellular and basement membrane associations. Immunogold double staining of elastic fibers showed a close colocalization of endostatin with fibulin-2, fibulin-1, and nidogen-2, but not with perlecan. Reasonable amounts of endostatin could be extracted from aorta and skin by EDTA, followed by detergents, with aorta being the richest source of the inhibitor identified so far. Solubilizations with collagenase and elastase were similar to fivefold less efficient. Immunoblots of aortic extracts detected major endostatin components of 22-25 kDa whereas skin extracts also contained some larger components. Solid-phase assays demonstrated distinct binding of recombinant mouse endostatin to the fibulins and nidogen-2, consistent with their tissue colocalization. Together, the data indicate several different ways for endostatin to be associated with the extracellular matrix, and its release may determine biological activation. This also defines a novel function for some elastic tissues. -Miosge, N., Sasaki, T., Timpl, R. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls.
引用
收藏
页码:1743 / 1750
页数:8
相关论文
共 44 条
[1]   Vascular development: Cellular and molecular regulation [J].
Beck, L ;
DAmore, PA .
FASEB JOURNAL, 1997, 11 (05) :365-373
[2]  
BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
[3]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[4]   THE 16-KILODALTON N-TERMINAL FRAGMENT OF HUMAN PROLACTIN IS A POTENT INHIBITOR OF ANGIOGENESIS [J].
CLAPP, C ;
MARTIAL, JA ;
GUZMAN, RC ;
RENTIERDELRUE, F ;
WEINER, RI .
ENDOCRINOLOGY, 1993, 133 (03) :1292-1299
[5]   Zinc-dependent dimers observed in crystals of human endostatin [J].
Ding, YH ;
Javaherian, K ;
Lo, KM ;
Chopra, R ;
Boehm, T ;
Lanciotti, J ;
Harris, BA ;
Li, Y ;
Shapiro, R ;
Hohenester, E ;
Timpl, R ;
Folkman, J ;
Wiley, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10443-10448
[6]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[7]   DIFFERENTIAL-EFFECTS OF SPARC AND CATIONIC SPARC PEPTIDES ON DNA-SYNTHESIS BY ENDOTHELIAL-CELLS AND FIBROBLASTS [J].
FUNK, SE ;
SAGE, EH .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (01) :53-63
[8]   A TUMOR SUPPRESSOR-DEPENDENT INHIBITOR OF ANGIOGENESIS IS IMMUNOLOGICALLY AND FUNCTIONALLY INDISTINGUISHABLE FROM A FRAGMENT OF THROMBOSPONDIN [J].
GOOD, DJ ;
POLVERINI, PJ ;
RASTINEJAD, F ;
LEBEAU, MM ;
LEMONS, RS ;
FRAZIER, WA ;
BOUCK, NP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6624-6628
[9]   Collagen XVIII is a basement membrane heparan sulfate proteoglycan [J].
Halfter, W ;
Dong, SC ;
Schurer, B ;
Cole, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (39) :25404-25412
[10]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364